The invention relates to organic electroluminescence devices containing indone carbazole derivatives.

The invention relates to organic electroluminescence devices containing indone carbazole derivatives.

Provided herein are methods for inhibiting PCSK9, reducing PCSK9 levels, and for treating or preventing related conditions and disorders, in a subject, which includes administering to a subject an effective amount of a compound which includes derivatized cycloalkyl[b]indoles, e.g., cyclopenta-, cyclohexa- and cyclohepta[b]indoles.

The present invention is directed to a compound represented by Structural Formula (A):

##STR00001##

or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.

The present invention is directed to a compound represented by Structural Formula (A):

##STR00001##

or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.

An organic compound represently by Chemical formula 1 and Chemical formula 2, an electronic component, and an electronic device. The two * in Chemical formula 2 are attached to any two adjacent * of the four * in Chemical formula 1 to form a fused ring. The organic compound can improve the electron transport performance of the electronic component. ##STR00001##

An organic compound represently by Chemical formula 1 and Chemical formula 2, an electronic component, and an electronic device. The two * in Chemical formula 2 are attached to any two adjacent * of the four * in Chemical formula 1 to form a fused ring. The organic compound can improve the electron transport performance of the electronic component. ##STR00001##

An organic compound represented by formula [1], where in formula [1], R.sub.1 to R.sub.8 are each independently selected from the group consisting of a hydrogen atom, a halogen atom, an alkyl group, and other substituents, and X.sub.1 is oxygen, sulfur, selenium, tellurium, or a CR.sub.9R.sub.10 group, in which R.sub.9 and R.sub.10 are each independently selected from the group consisting of a hydrogen atom, a halogen atom, an alkyl group, and other substituents, and at least one of R.sub.1 to R.sub.8 is a group represented by formula [2].

##STR00001##

An organic compound represented by formula [1], where in formula [1], R.sub.1 to R.sub.8 are each independently selected from the group consisting of a hydrogen atom, a halogen atom, an alkyl group, and other substituents, and X.sub.1 is oxygen, sulfur, selenium, tellurium, or a CR.sub.9R.sub.10 group, in which R.sub.9 and R.sub.10 are each independently selected from the group consisting of a hydrogen atom, a halogen atom, an alkyl group, and other substituents, and at least one of R.sub.1 to R.sub.8 is a group represented by formula [2].

##STR00001##

Discussed is an organic compound having a benzofluorenocarbazole core and an aromatic or hetero aromatic groups bonded to a specific positions of the benzofluorenocarbazole core, and an organic light emitting diode and an organic light emitting device including the compound. The organic compound has a narrow Stokes Shift between an absorption spectrum peak and an emission spectrum peak, it has a broad spectral overlapping area between its absorption wavelength range and an emission wavelength range of another luminous material. Therefore, it can emit light having high color purity and exhibit excellent luminous efficiency.